2017
DOI: 10.1186/s40886-017-0063-8
|View full text |Cite
|
Sign up to set email alerts
|

Dupuytren’s contracture: the status and impact of collagenase Clostridium histolyticum treatment in Austria

Abstract: Background: Over many decades, the treatment of Dupuytren's disease, a fibroproliferative disease of the hand, is the centre of various studies and publications. Surgical intervention has always been the method of choice, with fasciectomy being today's state of the art. Nevertheless, researchers also focused on conservative non-operative treatment methods of which collagenase Clostridium histolyticum (CCH) turned out to be very promising. With the release of CCH under the name Xiapex in 2010, its use increased… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 43 publications
0
0
0
Order By: Relevance